Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
World J Gastroenterol ; 21(10): 2905-11, 2015 Mar 14.
Article in English | MEDLINE | ID: mdl-25780287

ABSTRACT

AIM: To study the prevalence of human papillomavirus (HPV) in esophageal carcinoma in Tangshan, China, a high-incidence area. METHODS: Formalin-fixed, paraffin-embedded tissue specimens from 198 patients who were pathologically diagnosed with esophageal squamous cell carcinoma from 2011 to 2013 were obtained from a pathology department in Tangshan. DNA was extracted from all 198 specimens to detect HPV by polymerase chain reaction (PCR). ß-globin PCR was performed to check the quality of the DNA extraction procedure. PCR was performed to detect a wide range of HPV types, and type-specific PCR was performed to detect HPV types 16 and 18. Negative and positive controls were used for HPV 16 and 18 detection. RESULTS: The DNA extraction method in this study appeared to be more effective than other previously reported methods. After DNA extraction, more than 98% of the tissue specimens had an acceptable result in the DNA qualification test (ß-globin PCR). The overall prevalence of HPV in tumor tissues by GP6+/GP5+ PCR was 79.79%, and the prevalence of HPV types 16 and 18 was 40.40% and 47.47%, respectively. PCR demonstrated the presence of HPV, and direct sequencing confirmed the HPV genotypes. All HPV-positive PCR products were checked by DNA sequence analysis using DNAman and compared with the known HPV sequences listed in the Basic Local Alignment Search Tool database to evaluate the HPV types. This analysis confirmed the presence of HPV types 16 and 18. CONCLUSION: DNA of high-risk HPV types 16 and 18 is present in esophageal tumors, implicating HPV as a possible etiologic factor for esophageal squamous cell carcinoma.


Subject(s)
Carcinoma, Squamous Cell/epidemiology , Esophageal Neoplasms/epidemiology , Human papillomavirus 16/genetics , Human papillomavirus 18/genetics , Papillomavirus Infections/epidemiology , Base Sequence , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/virology , China/epidemiology , DNA, Viral/genetics , Esophageal Neoplasms/diagnosis , Esophageal Neoplasms/virology , Esophageal Squamous Cell Carcinoma , Human Papillomavirus DNA Tests , Humans , Molecular Sequence Data , Papillomavirus Infections/diagnosis , Papillomavirus Infections/virology , Polymerase Chain Reaction , Predictive Value of Tests , Prevalence , Risk Factors
2.
Life Sci ; 127: 46-52, 2015 Apr 15.
Article in English | MEDLINE | ID: mdl-25747255

ABSTRACT

AIMS: The integration preferences of human papillomavirus (HPV) have been intensively studied and contested over recent years. To disclose the integration preferences of high-risk HPV in cervical cancer, HPV transcriptional sites and features in different cervical cancer cell lines were identified. MAIN METHODS: In this study, three cervical cancer cell lines (CaSki, HeLa, and SiHa) were subjected for HPV genome status determination by amplification of papillomavirus oncogene transcripts (APOT) assay. The numbers of viral copies in human genomes and numbers of viral-human fusion mRNAs in three HPV-integrated cervical cancer cell lines were measured and analysed. KEY FINDINGS: The results revealed that the gene desert region 8q24 of the HPV type 18 integrated HeLa cell line and the 13q21-22 region of the HPV type 16 integrated CaSki and SiHa cell lines were hotspots for HPV integration, and the numbers of viral copies in the human genomes of the three cell lines that we detected were not in accordance with those reported in previous studies. SIGNIFICANCE: Integration of the HPV genome into the host cell chromosome suggests that persistent HPV infection is vital for malignant cell transformation and carcinogenesis. This study provides information to benefit health care professionals seeking more comprehensive and accurate diagnostics for HPV-related disease"? Please check, and amend as necessary.


Subject(s)
Cell Line, Tumor , Genome, Viral/genetics , Human papillomavirus 16/genetics , Human papillomavirus 18/genetics , Uterine Cervical Neoplasms/genetics , Virus Integration/genetics , Female , Gene Dosage , Gene Expression Regulation, Viral/genetics , HeLa Cells , Humans , RNA, Viral/genetics , Transcription Initiation Site
SELECTION OF CITATIONS
SEARCH DETAIL
...